Public Comment

Regulations.gov - Comment

Att. 2a: 60Day FRN Comment - I-Cat

Page 1 of 9

CDC I-Catalyst Program 0920-16AOW PUBLIC COMMENT
ON FEDERAL REGISTER BELOW
The is a Comment on the Centers for Disease Control and
Prevention (CDC) Notice: CDC I-Catalyst Program 092016AOW 2016-13982
For related information, Open Docket Folder

Comment Period Closed
Aug 15 2016, at 11:59 PM ET

ID: CDC-2016-0050-0002
Tracking Number: 1k0-8qb2-ry0e

Comment
Jean Public
From:
Saturday, June 18, 2016 4:01 PM
Sent:
OMB-Comments (CDC);
To:
[email protected]
[email protected]; [email protected];
Cc:
[email protected]
PUBLIC COMMENT ON FEDERAL
Subject:
REGISTER BELOW

Document Information
Date Posted:
Jun 20, 2016
Show More Details

FIRST THING I WENT TO REGULATIONS GOV AS THIS
INEPT AGENCY SAID TO DO AND LOOKED FOR AND
TRIED TO FIND 2016-13982. NO LUCK. THEN I TRIED
CDC-2016-0050. NO LUCK. DIDNT WORK. AGAIN
CDC HAS FAILED TO LIST ON REGULATIONS.GOV THE
WAY FOR THE PUBLIC TO COMMENT. SO I HAVE TO
COMMENT IN AN ALTERNATE WAY BECAUSE OF THE
COMPLETE FAILURE OF THE CDC. THIS IS AN
EXAMPLE OF THE SLOPPY, INEPT WAY THIS AGENCY
OPERATES. FAT CAT BLOATED BUREAUCRACY
STUPIDITY.
THIS PROGRAM AS USUAL RELIES ONLY ON
EMPLOYEE IMPERIALISM. THIS AGENCY COMPLETELY
DISRESPECTS THE PUBLIC. EVEN WHEN HIGHLY
QUALIFIED P UBLIC HAS QUESTONS, NONE OF THEM
ARE
EVER ANSWERED BY THE SECRETIAVE, SNEAKY
EMPLOYEES WHO WORK IN THIS AGENCY, WHO ARE
AFRAID TO STAND UP FOR WHAT THEY TRY TO PUSH
ONT HE GENRAL PUBLIC. THE HARMFUL VACCINES.
THIS IS JUST MORE OF THE SAME CDC BLINDNESS TO
PUBLIC DEMANDS ON WHAT THEY NEED AND
WANT FROM THIS AGENCY. AND THE DISRESPECT
GIVEN TO THAT PUBLIC WHEN THEY WANT
INFORMATION AND ANSWERS FROM THE HARMFUL

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 2 of 9

ACTIONS OF THIS AGENCY. THE PUBLIC COUNTS
FOR NOTHING WITH THESE IMPERIALISTS AT THIS
AGENCY. I OPPOSE THIS PROJECT. I OPPOSE ALL
FUNDING FOR THIS PROJECT. THE FUNDS FOR THIS
PROJECT SHOULD BE ZERO. WE DONT NEED MORE
EMPLOYEE IDEAS. WE NEED MORE PUBLIC IDEAS
COUNTENANCED AND INVESTIGATED BY THIS
AGENCY.
GOVT FOR TH EPEOPLE VANISHED FROM THIS
AGENCY. THIS AGENCY WORKS ON GOVT FOR THE
IMPERIALIST EMPLOYEES. THIS IS AN EVIL CORRUPT
AGENCY. IT NEEDS TO BE SHUT DOWN. WE NEED TO
START FRESH. THE EFFECTS OF BIG PHARMA AND
BIG MEDICINE HAVE BEEN FAR TOO CORRUPTING
HERE. ALL IT IS IS ABOUT MONEY FOR THE
IMPERIALISTS WHO REVOLVE FROM BIG PHARMA TO
CDC
AND BACK AGAIN, WITH RAISES EACH TIME FOR
WORK THAT SCREWS THE AMERICAN PUBLIC. THIS IS
MORE FAKERY THIS PROPOSAL SUCKS. THIS
COMMENT IS FOR THE PUBLIC RECORD. PLEASE
RECEIPT.
JEAN PUBLIEE [email protected]
> Federal
> Register Volume 81, Number 114 (Tuesday, June 14,
2016)] [Notices]
> [Pages 38707-38709] From the Federal Register Online
via the
> Government Publishing Office [www.gpo.gov] [FR Doc No:
2016-13982]
>
>
> --------------------------------------------------------------------->>
> DEPARTMENT OF HEALTH AND HUMAN SERVICES
>
> Centers for Disease Control and Prevention
>
> [60Day-16-16AOW; Docket No. CDC-2016-0050]
>
>
> Proposed Data Collection Submitted for Public Comment
and
> Recommendations
>
> AGENCY: Centers for Disease Control and Prevention
(CDC), Department
> of Health and Human Services (HHS).
>
> ACTION: Notice with comment period.
>
> --------------------------------------------------------------------->>
> SUMMARY: The Centers for Disease Control and

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 3 of 9

Prevention (CDC), as part
> of its continuing effort to reduce public burden and
maximize the
> utility of government information, invites the general public
and
> other Federal agencies to take this opportunity to
comment on proposed
> and/or continuing information collections, as required by
the
> Paperwork Reduction Act of 1995. This notice invites
comment on the
> CDC I- Catalyst program. The I-Catalyst program is
intended to help
> CDC employees get their ideas out of the starting blocks
and down the
> track through a discovery,
>
> [[Page 38708]]
>
> ideation, and prototyping process. The expected result is
that CDC
> staff will be empowered to implement innovative strategies
and
> solutions that create value for a set of beneficiaries.
>
> DATES: Written comments must be received on or before
August 15, 2016.
>
> ADDRESSES: You may submit comments, identified by
Docket No.
> CDC-2016> 0050 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow
>
the
> instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection
>
Review Office,
> Centers for Disease Control and Prevention, 1600 Clifton
Road NE.,
> MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include
>
the agency
> name and Docket Number. All relevant comments
received will be posted
> without change to Regulations.gov, including any personal
information
> provided. For access to the docket to read background
documents or
> comments received, go to Regulations.gov.
>
Please note: All public comment should be submitted
>
through the
> Federal eRulemaking portal (regulations.gov) or by U.S.
mail to the
> address listed above.
>
>

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 4 of 9

> FOR FURTHER INFORMATION CONTACT: To request
more information on the
> proposed project or to obtain a copy of the information
collection
> plan and instruments, contact the Information Collection
Review
> Office, Centers for Disease Control and Prevention, 1600
Clifton Road
> NE., MS- D74, Atlanta, Georgia 30329; phone: 404-6397570; Email:
> [email protected].
>
> SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995
> (PRA) (44 U.S.C. 3501-3520), Federal agencies must
obtain approval
> from the Office of Management and Budget (OMB) for
each collection of
> information they conduct or sponsor. In addition, the PRA
also
> requires Federal agencies to provide a 60-day notice in
the Federal
> Register concerning each proposed collection of
information, including
> each new proposed collection, each proposed extension
of existing
> collection of information, and each reinstatement of
previously
> approved information collection before submitting the
collection to
> OMB for approval. To comply with this requirement, we
are publishing
> this notice of a proposed data collection as described
below.
Comments are invited on: (a) Whether the proposed
>
collection of
> information is necessary for the proper performance of the
functions
> of the agency, including whether the information shall
have practical
> utility; (b) the accuracy of the agency's estimate of the
burden of
> the proposed collection of information; (c) ways to
enhance the
> quality, utility, and clarity of the information to be collected;
(d)
> ways to minimize the burden of the collection of
information on
> respondents, including through the use of automated
collection
> techniques or other forms of information technology; and
(e) estimates
> of capital or start- up costs and costs of operation,
maintenance, and
> purchase of services to provide information. Burden
means the total
> time, effort, or financial resources expended by persons to

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 5 of 9

generate,
> maintain, retain, disclose or provide information to or for a
Federal
> agency.
> This
> includes the time needed to review instructions; to
develop, acquire,
> install and utilize technology and systems for the purpose
of
> collecting, validating and verifying information, processing
and
> maintaining information, and disclosing and providing
information; to
> train personnel and to be able to respond to a collection of
>
> information, to search data sources, to complete and
review the
> collection of information; and to transmit or otherwise
disclose the
> information.
>
> Proposed Project
>
CDC I-Catalyst Program--New--Office of the
>
Associate Director for
> Science, Centers for Disease Control and Prevention
(CDC).
>
> Background and Brief Description
>
The CDC Office of Technology and Innovation (OTI)
>
within Office of
> the Associate Director for Science (OADS) fosters
innovative science
> and promotes the testing and implementation of innovative
ideas that
> improve CDC's ability to have public health impact. To arm
CDC staff
> with an expanded skill-set and tools to evaluate and
translate their
> insights and ideas into solutions, CDC developed an
experiential
> innovation curriculum called I-Catalyst. The program was
created with
> the belief that innovation should be customer driven, be
based on user
> research, and is something people at all levels of an
organization can
> engage in.
The goal of the I-Catalyst program is to help CDC
>
employees test
> and explore their ideas through a discovery, ideation, and
prototyping
> process. I-Catalyst offers a process for defining problems
and
> developing strategies to solutions that will help improve
the quality

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 6 of 9

> and efficiency of innovation efforts and, as a result, overall
> performance. Through the I-Catalyst Program, teams work
to define and
> articulate their problem space to find effective solutions.
> Participating teams will go through a hypothesis-testing,
scientific
> method of discovery to gather important insights and
identify issues
> associated with their projects. Teams are forced ``out of
the
> classroom'' to conduct interviews, study
customer/stakeholder needs,
> collect feedback, and find partnership opportunities. It is
expected
> that participants will leave the program with the ability to
evaluate
> and translate their insights into solutions.
The I-Catalyst program provides CDC staff with real>
world,
> hands-on entrepreneurship training. Through I-Catalyst
CDC staff make
> hypothesis about how the world works, and then test them
by getting
> out of the building and talking to customers and/or
stakeholders. Only
> conversations with potential customers/stakeholders can
provide the
> facts from which hypotheses are proven or disproven
about whether a
> solution (whether a product, process, etc.) creates value
for the
> intended beneficiaries. Participants have to go out into the
world and
> learn by doing. The process will engage
customers/stakeholders in a
> process that will identify what they most value and need
and what
> their top barriers and pain points are, and source solutions
that will
> have high levels of efficacy and user acceptability.
I-Catalyst combines in-class lectures with out-of-class
>
learning
> and interactions with various customers/stakeholders. This
curriculum
> requires full participation from the entire team. The
program guides
> teams and individuals through a series of workshops that
helps
> participants articulate a problem, create evidence-based
plan for
> assessment, and conduct unstructured interviews with
customers/
> stakeholders. Ongoing technical assistance and support
from a cadre of
> experts is provided to teams as they define the problem,
map their
> operational model, and identify and interact with

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 7 of 9

customers/
> stakeholders. Each team member must commit to in-depth
preparation,
> attendance at the lectures and workshops, and at least 15
additional
> hours per week for customer discovery.
Teams will be spending a significant amount of time
>
in between
> each of the lectures outside the class talking to customers.
Each week
> teams will conduct a minimum of five customer interviews
with
> individuals who represent different segments of
customers/stakeholders
> whom they expect will gain value through their solution or
will
> benefit from value streams that are being produced by
their solution
> (in terms of social and/or environmental impact). The
types of
> customers or stakeholders teams'
>
> [[Page 38709]]
>
> interview will be specific to the proposed solution and
context. For
> example, teams may interview government employees if
the solution is
> intended to improve how government employees do their
work.
> On the
> other hand, teams may interview individuals who work
industry and
> businesses if the teams determines that they are the
intended
> beneficiaries.
Using a generic information collection plan, this data
>
collection
> covers qualitative information to be obtained through onsite,
> unstructured interviews with individuals who represent the
customers
> or stakeholders CDC teams are attempting to serve or
benefit.
> CDC
> anticipates conducting I-Catalyst with three cohorts of
teams over the
> next two years. With each I-Catalyst cohort teams will
interview their
> customers/stakeholders for an average of 30 minutes.
Each team will
> interview approximately 50 respondents. With 8-10 teams
participating
> in each of the three I-Catalyst training cohorts,
approximately 1,500
> respondents will be interviewed. Of these, approximately
40% of

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 8 of 9

> individuals will be internal CDC/ATSDR staff and 60% will
be external
> partners, stakeholders, or customers. Data to be collected
includes
> information regarding what they most value and need and
their top
> barriers and pain points.
CDC expects that teams participating in the I-Catalyst
>
will be
> empowered to implement innovative strategies and
solutions that create
> value for a set of beneficiaries. The ultimate goal of the
I-Catalyst
> program is to give CDC staff skills to successfully transfer
knowledge
> into value-based solutions that benefit society and
broaden the
> agency's impact.
Participation in the I-Catalyst interviews is completely
>
> voluntary.
> A three-year approval is requested. There is no cost to
respondents
> other than their time.
>
Estimated Annualized Burden
>
> Hours
> ---------------------------------------------------------------------> ----------------------------------------->
>
Average
>
Number
> of
Number of
burden per
Total burden
Type of respondents
Form name
>
> respondents responses per response (in
(in hrs.)
>
>
respondent
hrs.)
> ---------------------------------------------------------------------> -----------------------------------------> Cohort 1:
External Partners,
Forms will not
>
> 500
1
1
500
Stakeholders, or
be used.
>
>
Customers.
> Cohort 2:
External Partners,
Forms will not
>
> 500
1
1
500
Stakeholders, or
be used.
>
>
Customers.
> Cohort 3:
External Partners,
Forms will not
>
> 500
1
1
500
Stakeholders, or
be used.
>
>
Customers.
>
> --------------------------------------------------------------Total................. ................
>
> .............. .............. ..............

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016

Regulations.gov - Comment

Page 9 of 9

> 1,500
> ---------------------------------------------------------------------> ----------------------------------------->
>
> Leroy A. Richardson,
> Chief, Information Collection Review Office, Office of
Scientific
> Integrity, Office of the Associate Director for Science,
Office of the
> Director, Centers for Disease Control and Prevention.
> [FR Doc. 2016-13982 Filed 6-13-16; 8:45 am] BILLING
CODE 4163-18-P
>
>
>

https://www.regulations.gov/document?D=CDC-2016-0050-0002

9/22/2016